WOLSTANTON MEDICAL CENTRE
PALMERSTON STREET, WOLSTANTON, NEWCASTLE-UNDER-LYME, NEWCASTLE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 40 | 52 | 76.9% | |
| HF 4 | 2011 | 40 | 51 | 78.4% | |
| HF 4 | 2012 | 41 | 49 | 83.7% | |
| HF 4 | 2013 | 44 | 54 | 81.5% | |
| HF004 | 2015 | 21 | 24 | 87.5% | |
| HF004 | 2016 | 25 | 31 | 80.6% | |
| HF004 | 2017 | 24 | 28 | 85.7% | |
| HF004 | 2018 | 26 | 30 | 86.7% | |
| HF004 | 2019 | 31 | 34 | 91.2% | |
| HF004 | 2020 | 35 | 36 | 97.2% | |
| HF006 | 2021 | 34 | 36 | 94.4% | |
| HF006 | 2022 | 43 | 44 | 97.7% | |
| HF006 | 2023 | 48 | 50 | 96.0% |
